Shalita A - Search Results

1

Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.

Shalita A, Miller B, Menter A, Abramovits W, Loven K, Kakita L. Shalita A, et al. J Drugs Dermatol. 2005 Mar-Apr;4(2):153-8. J Drugs Dermatol. 2005. PMID: 15776771 Clinical Trial.

2

Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.

Tanghetti E, Abramovits W, Solomon B, Loven K, Shalita A. Tanghetti E, et al. Among authors: shalita a. J Drugs Dermatol. 2006 Mar;5(3):256-61. J Drugs Dermatol. 2006. PMID: 16573259 Clinical Trial.

3

Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study.

Fleischer AB Jr, Shalita A, Eichenfield LF, Abramovits W, Lucky A, Garrett S; Dapsone Gel in Combination Treatment Study Group. Fleischer AB Jr, et al. Among authors: shalita a. J Drugs Dermatol. 2010 Jan;9(1):33-40. J Drugs Dermatol. 2010. PMID: 20120423 Clinical Trial.

4

The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.

Shalita AR, Myers JA, Krochmal L, Yaroshinsky A; Clindamycin Foam Study Group. Shalita AR, et al. J Drugs Dermatol. 2005 Jan-Feb;4(1):48-56. J Drugs Dermatol. 2005. PMID: 15696985 Clinical Trial.

5

Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.

Tanghetti E, Dhawan S, Green L, Del Rosso J, Draelos Z, Leyden J, Shalita A, Glaser DA, Grimes P, Webster G, Barnett P, Le Gall N. Tanghetti E, et al. Among authors: shalita a. J Drugs Dermatol. 2010 May;9(5):549-58. J Drugs Dermatol. 2010. PMID: 20480800 Clinical Trial.

6

Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study.

Shalita AR, Chalker DK, Griffith RF, Herbert AA, Hickman JG, Maloney JM, Miller BH, Tschen EH, Chandraratna RA, Gibson JR, Lew-Kaya DA, Lue JC, Sefton J. Shalita AR, et al. Cutis. 1999 Jun;63(6):349-54. Cutis. 1999. PMID: 10388959 Clinical Trial.

7

Topical retinoids in the treatment of acne vulgaris.

Bershad S, Poulin YP, Berson DS, Sabean J, Brodell RT, Shalita AR, Kakita L, Tanghetti E, Leyden J, Webster GF, Miller BH. Bershad S, et al. Among authors: shalita ar. Cutis. 1999 Aug;64(2 Suppl):8-20; quiz 21-3. Cutis. 1999. PMID: 10472493 Review. No abstract available.

8

Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.

Shalita AR, Berson DS, Thiboutot DM, Leyden JJ, Parizadeh D, Sefton J, Walker PS, Gibson JR; Tazarotene Cream in Acne Clinical Study Investigator Group. Shalita AR, et al. Clin Ther. 2004 Nov;26(11):1865-73. doi: 10.1016/j.clinthera.2004.11.012. Clin Ther. 2004. PMID: 15639698

9

The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review.

Patel M, Bowe WP, Heughebaert C, Shalita AR. Patel M, et al. J Drugs Dermatol. 2010 Jun;9(6):655-64. J Drugs Dermatol. 2010. PMID: 20645527 Review.

10

Inflammatory acne management with a novel prescription dietary supplement.

Shalita AR, Falcon R, Olansky A, Iannotta P, Akhavan A, Day D, Janiga A, Singri P, Kallal JE. Shalita AR, et al. J Drugs Dermatol. 2012 Dec;11(12):1428-33. J Drugs Dermatol. 2012. PMID: 23377512 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters